Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62011TA0502

    Case T-502/11: Judgment of the General Court of 17 May 2013 — Sanofi Pasteur MSD v OHIM — Mundipharma (Representation of two devices of crossing sickles) (Community trade mark — Opposition proceedings — Application for Community figurative mark representing two devices of crossing sickles — Earlier national and international figurative marks representing two devices of ribbons — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation No 207/2009)

    OJ C 189, 29.6.2013, p. 21–21 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    29.6.2013   

    EN

    Official Journal of the European Union

    C 189/21


    Judgment of the General Court of 17 May 2013 — Sanofi Pasteur MSD v OHIM — Mundipharma (Representation of two devices of crossing sickles)

    (Case T-502/11) (1)

    (Community trade mark - Opposition proceedings - Application for Community figurative mark representing two devices of crossing sickles - Earlier national and international figurative marks representing two devices of ribbons - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation No 207/2009)

    2013/C 189/41

    Language of the case: German

    Parties

    Applicant: Sanofi Pasteur MSD SNC (Lyon, France) (represented by: T. de Haan, P. Péters and V. Wellens, lawyers)

    Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, acting as Agent)

    Other party to the proceedings before the Board of Appeal of OHIM: Mundipharma AG (Basel, Switzerland) (represented by: F. Nielsen, lawyer)

    Re:

    Action brought against the decision of the Fourth Board of Appeal of OHIM of 22 July 2011 (Case R 1904/2010-4), relating to opposition proceedings between Sanofi Pasteur MSD SNC and Mundipharma AG

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Sanofi Pasteur MSD SNC to pay the costs.


    (1)  OJ C 340, 19.11.2011.


    Top